Stem Cell Transplant Research
Backed by funding from the National Institutes of Health and other national organizations, our physicians and researchers continually engage in research and clinical trials. The goals of our research are three-fold:
- Improve the success of stem cell transplants in people with leukemia, lymphoma, and other hematologic malignancies. This includes reducing the potential side effects caused by treatment and reducing the risk of cancer or blood disease re-occurring after transplant.
- Help more patients who need a stem cell transplant get one by using multiple cord blood transplants and other innovative approaches.
- Continue to explore the successful use of stem cell transplants in treating sickle cell anemia and other blood diseases.
At any one time, we have about a dozen clinical trials under way that are related to stem cell transplantation. Many of our patients participate in and benefit from research protocols as part of their treatment plans.